Document And Entity Information
Document And Entity Information | Feb. 12, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Feb. 12, 2024 |
Entity Registrant Name | MiNK Therapeutics, Inc. |
Entity Central Index Key | 0001840229 |
Entity Emerging Growth Company | true |
Entity File Number | 001-40908 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 82-2142067 |
Entity Address, Address Line One | 149 Fifth Avenue |
Entity Address, Address Line Two | Suite 500 |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10010 |
City Area Code | 212 |
Local Phone Number | 994-8250 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common Stock, par value $0.00001 per share |
Trading Symbol | INKT |
Security Exchange Name | NASDAQ |